Exact Mass: 420.2359206
Exact Mass Matches: 420.2359206
Found 500 metabolites which its exact mass value is equals to given mass value 420.2359206
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Testosterone Phenylpropionate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
tingenone
D000970 - Antineoplastic Agents
Levocabastine
C26H29FN2O2 (420.22129459999996)
Levocabastine is only found in individuals that have used or taken this drug. It is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.Levocabastine is a potent, selective histamine H1-receptor antagonist. It works by competing with histamine for H1-receptor sites on effector cells. It thereby prevents, but does not reverse, responses mediated by histamine alone. Levocabastine does not block histamine release but, rather, prevents histamine binding and activity. Levocabastine also binds neurotensin 2 receptors and serves as a neurotensin agonist. This can induce some degree of analgesia. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Dimethyl 3-methoxy-4-oxo-5-(8,11,14-pentadecatrienyl)-2-hexenedioate
Dimethyl 3-methoxy-4-oxo-5-(8,11,14-pentadecatrienyl)-2-hexenedioate is found in cereals and cereal products. Dimethyl 3-methoxy-4-oxo-5-(8,11,14-pentadecatrienyl)-2-hexenedioate is a constituent of etiolated seedlings of Sorghum bicolor (sorghum)
CPA(18:0/0:0)
C21H41O6P (420.26406160000005)
cPA(18:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis. [HMDB] cPA(18:0/0:0) is a cyclic phosphatidic acid or cyclic lysophosphatidic acid. It is a glycerophospholipid in which a cyclic phosphate moiety occupies two glycerol substitution sites. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1). Fatty acids containing 16 and 18 carbons are the most common. Cyclic phosphatidic acids have been detected in a wide range of organisms including humans, especially in the brain but also in serum (at a concentration of 10-7M). cPAs have a cyclic phosphate at the sn-2 and sn-3 positions of the glycerol carbons, and this structure is absolutely necessary for their activities. In particular, it is found in tissues subject to injury, and while it may have some similar signalling functions to lysophosphatidic acid per se, it also has some quite distinct biological activities. For example, cyclic phosphatidic acid is known to be a specific inhibitor of DNA polymerase alpha. It has an appreciable effect on the inhibition of cancer cell invasion and metastasis.
Armillane
Armillane is found in mushrooms. Armillane is a metabolite of Armillaria mellea (honey mushroom Metabolite of Armillaria mellea (honey mushroom). Armillane is found in mushrooms.
(8alpha,10alpha,13alpha,17beta)-17-[(4-Hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
Cabastine
C26H29FN2O2 (420.22129459999996)
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
DGAT-1 inhibitor 2
DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. IC50 value: Target: DGAT-1 Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. Findings from genetically modified mice as well as pharmacological studies suggest that inhibition of DGAT1 is a promising strategy for the treatment of obesity and type 2 diabetes.
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents
Testosterone phenylpropionate
8-(3-(1-((3-Fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinolin-4-one
C26H29FN2O2 (420.22129459999996)
8-[3-[1-[(3-Fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline-4-one
C26H29FN2O2 (420.22129459999996)
Trichoverrol A
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
8beta-Acetoxy-3beta-angeloyloxy-5alpha-hydroxycostic acid methyl ester
Methyl ent-16-acetoxy-6,13E-labdadien-15,17-dioate
Butanoic acid,(2S,2aR,3R,5aR,6R,9S,9aS,9bS,12R)-decahydro-12-hydroxy-3,6,9-trimethyl-13-methylene-7-oxo-2,9-pentano-2H-furo[2,3,4-ef][3]benzoxepin-3-ylester
Deacetylpseudolaric acid A 2,3-dihydroxypropyl ester
2beta,3alpha-Diacetoxy-11beta,14alpha-dihydroxy-1(15),8(19)-trinervitadiene
9alpha,14alpha-Diacetoxy-2beta,3alpha-dihydroxy-1(15),8(19)-trinervitadiene
[4beta(2Z,4E,6S,7S)]- 12,13-Epoxytrichothec-9-ene-4,16-diol 4-(6,7-dihydroxy-2,4-octadienoate)
Trichoverrol B
[4beta(2Z,4E,6S,7R)]-12,13-Epoxytrichothec-9-ene-4,16-diol 4-(6,7-dihydroxy-2,4-octadienoate)
(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl (2E,4E)-6,7-dihydroxy-2,4-octadienoate
4-Benzyl-2-({4-[5-(trifluoromethyl)-2-pyridinyl]piperazino}methyl)
(2Z,6E,10Z)-12-acetyloxy-10-(acetyloxymethyl)-6-methyl-2-(4-methylpent-3-enyl)dodeca-2,6,10-trienoic acid
3beta,5,12beta,14-Tetrahydroxy-19-oxo-5beta,14beta-card-20(22)-enolid|3beta,5,12beta,14-tetrahydroxy-19-oxo-5beta,14beta-card-20(22)-enolide|antiarigenin
9,20-Di-Ac-(2beta,3alpha,9beta)-1(15),8(19)-Trinervitadiene-2,3,9,20-tetrol|9beta,20-diacetoxy-2beta,3alpha-dihydroxy-1(15),8(19)-trinervitadiene
12,13-Di-Ac-(1alpha,5beta,6beta,9alpha,12xi,13xi)-3,10,14-Prenylguaiatriene-6,9,12,13-tetrol
Armillane
16,19-diacetoxy-ent-labda-8(17),13E-dien-15-oic acid
methyl 2alpha-abieta-11(12)-ene-9alpha,13alpha-endoperoxyl malonate
3-oxo-14,3-oxy-3(4->18)-abeo-brevia-1,4(18),12,2,4-pentaene 1,5-lactone|brevione C
16,17-Diacetoxy-16beta-(-)-kauran-19-saeure|16alpha,17-diacetoxy-ent-kauran-19-oic acid|19-Carboxylic acid,16,17-di-Ac-(ent-16betaOH)-16,17,19-Kauranetriol
casebalansin B|ent-2beta-hydroxy-3,4-dihydro-4alpha-isozuelanin|rel-(2R,4R,5S,8R,9R,10S,18R,19R)-18,19-diacetoxy-18,19-epoxycleroda-13(16),14-dien-2-ol
7alpha,17beta-dihydroxy-15,17-oxidospongian-16-one 7-butyrate|Aplyroseol 1
17alpha-strophadogenin|5beta,14beta,16beta-trihydroxy-19-oxo-17alpha-card-20(22)-enolide
cadiyenol|methyl 5-[(E)-9-hydroxy-1-(1-hydroxyhexyl)-2-methoxyundeca-3,10-diene-5,7-diynyloxy]pentanoate
6,7-Di-Ac-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
rel-(7S,8R,1R,3S,4S,5S)-Delta8-4-hydroxy-3,4,5,3,5-pentamethoxy-1,2,3,4,5,6-hexahydro-2-oxo-7.3,8.1-neolignan
2-(10-acetyloxypentadec-8-enyl)-4,6-dihydroxybenzoic acid
15alpha,16beta-diacetoxy-15,16-epoxy-neo-cleroda-4(18),12Z-dien-14beta-ol
3-hydroxy-24-methyl-25-oxo-hexacosa-5,7,9,11,13,15,17,19,21,23-decaenoic acid|laetiporic acid
7??,18-Diacetoxy,9??,13??-epi-dioxiabiet-8(14)-ene
9alpha-hydroxy-6beta-(6,6-dimethoxyhex-2E,4E-dienoyloxy)-5alpha-drim-7-en-11,12-olide|ustusolate D
12,17-diacetoxy-15-hydroxy-2-oxo-3,13E(14)-diene-clerodane
(2E,4E)-cyclo-[(NMe-L-Ala)-(NMe-L-Val)-(Nalpha-6-oxohexa-2,4-dienoyl-L-Orn)]|sclerotiotide F
(2S,13Z)-2,5-diacetoxy-12-hydroxy-4,10-secospata-13(15),17-dien-10-one
9beta-hydroxy-14-isobutyryloxyalbicolide-15-O-isobutyrate
6-Butanoyl 鈥樎?6alpha,17beta)-15,17-Epoxy-6,17-dihydroxy-16-spongianone|6alpha,17beta-dihydroxy-15,17-oxidospongian-16-one 6-butyrate
Ent-11E,13?鈥?15?鈥?16?鈥?form-15,16-Di-Ac-15,16-Epoxy-4(18),11-clerodadiene-13,15,16-triol
10alpha,14alpha-diacetoxy-7,8-epoxydolabella-3(E),18-dien-2alpha-ol
20(R)-15alpha-acetoxy-6beta-hydroxy-20-methoxy-6,20alpha-epoxy-6,7-seco-1alpha,7-olide-ent-kaur-16-ene|20(S)-15alpha-acetoxy-6beta -hydroxy-20-methoxy-6,20alpha-epoxy-6,7-seco-ent-kanr-16-en-1alpha,7-olide|isodonhenrin B|isorosthin C
6beta,7beta-diacetoxy-15,16-epoxylabda-13(16),14-diene-9alpha-ol|lagopsin B
1alpha-acetoxy-5alpha,7beta-dihydroxy-12alpha-methoxycassa-14(17),13(15)-dien-16,12-olide|caesalpin G
Caesalpine A
(7R,8S,2R,3R,4R,5S)-Delta(8)-2,4-dihydroxy-3,4,5,3,5-pentamethoxy-2,3,4,5-tetrahydro-2-oxo-7.3,8.5-neolignan|nectamazin C
ent-3beta,19-diacetoxy-12beta,15alpha-dihydroxykaur-16-ene
15xi,16xi-diacetoxy-15,16-epoxy-neo-cleroda-4(18),11E-dien-13xi-ol
15,16-Diacetoxy-12,13-15,16-diepoxy-ent-clerod-3-ene|Di-Ac-(ent-12S,13R,15S,16R)-12.13:15,16-Diepoxy-3-clerodene-15,16-diol
2,5-Diacetoxy-3-tridecyl-6-methyl-1,4-benzoquinone
1alpha,6beta-diacetoxy-8,13-epoxy-labd-14-ene-11-one|coleolin
1alpha-Hydroxy-6-O-isobutyryl-3beta-isobutyryloxysteiractinolid
(1R*,3S*,4R*,6S*)-9-(Acetoxy)-4-acetoxy-1-[(2Z)-2-methylbut-2-enoyloxy]bisabol-2(3),10(11)-diene|(1R*,4S*,6R*)-4,9-bis(acetyloxy)-1-{[(2Z)-2-methylbut-2-enoyl]oxy}bisabol-2(3),10(11)-diene|(1R*,4S*,6R*)-4-(acetyloxy)-6-[3-(acetyloxy)-1,5-dimethylhex-4-enyl]-3-methylcyclohex-2-en-1-yl (2Z)-2-methylbut-2-enoate
[(5R,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E)-6,7-dihydroxyocta-2,4-dienoate
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one
C23H32O7_(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl (2E,4E)-6,7-dihydroxy-2,4-octadienoate
C23H32O7_1-Phenanthrenecarboxylic acid, 10-(acetyloxy)-1,2,3,4,4a,9,10,10a-octahydro-4,5,9-trihydroxy-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester
methyl 10-acetyloxy-4,5,9-trihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one [IIN-based: Match]
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one [IIN-based on: CCMSLIB00000848593]
methyl 10-acetyloxy-4,5,9-trihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate_major
(2Z,6E,10Z)-12-acetyloxy-10-(acetyloxymethyl)-6-methyl-2-(4-methylpent-3-enyl)dodeca-2,6,10-trienoic acid_major
(2Z,6E,10Z)-12-acetyloxy-10-(acetyloxymethyl)-6-methyl-2-(4-methylpent-3-enyl)dodeca-2,6,10-trienoic acid_minor
Ala Ala Phe Ile
Ala Ala Phe Leu
Ala Ala Ile Phe
Ala Ala Leu Phe
Ala Phe Ala Ile
Ala Phe Ala Leu
Ala Phe Ile Ala
Ala Phe Leu Ala
Ala His Pro Pro
Ala Ile Ala Phe
Ala Ile Phe Ala
Ala Ile Met Ser
C17H32N4O6S (420.20424520000006)
Ala Ile Ser Met
C17H32N4O6S (420.20424520000006)
Ala Leu Ala Phe
Ala Leu Phe Ala
Ala Leu Met Ser
C17H32N4O6S (420.20424520000006)
Ala Leu Ser Met
C17H32N4O6S (420.20424520000006)
Ala Met Ile Ser
C17H32N4O6S (420.20424520000006)
Ala Met Leu Ser
C17H32N4O6S (420.20424520000006)
Ala Met Ser Ile
C17H32N4O6S (420.20424520000006)
Ala Met Ser Leu
C17H32N4O6S (420.20424520000006)
Ala Met Thr Val
C17H32N4O6S (420.20424520000006)
Ala Met Val Thr
C17H32N4O6S (420.20424520000006)
Ala Pro His Pro
Ala Pro Pro His
Ala Ser Ile Met
C17H32N4O6S (420.20424520000006)
Ala Ser Leu Met
C17H32N4O6S (420.20424520000006)
Ala Ser Met Ile
C17H32N4O6S (420.20424520000006)
Ala Ser Met Leu
C17H32N4O6S (420.20424520000006)
Ala Thr Met Val
C17H32N4O6S (420.20424520000006)
Ala Thr Val Met
C17H32N4O6S (420.20424520000006)
Ala Val Met Thr
C17H32N4O6S (420.20424520000006)
Ala Val Thr Met
C17H32N4O6S (420.20424520000006)
Cys Ile Ser Val
C17H32N4O6S (420.20424520000006)
Cys Ile Val Ser
C17H32N4O6S (420.20424520000006)
Cys Leu Ser Val
C17H32N4O6S (420.20424520000006)
Cys Leu Val Ser
C17H32N4O6S (420.20424520000006)
Cys Ser Ile Val
C17H32N4O6S (420.20424520000006)
Cys Ser Leu Val
C17H32N4O6S (420.20424520000006)
Cys Ser Val Ile
C17H32N4O6S (420.20424520000006)
Cys Ser Val Leu
C17H32N4O6S (420.20424520000006)
Cys Thr Val Val
C17H32N4O6S (420.20424520000006)
Cys Val Ile Ser
C17H32N4O6S (420.20424520000006)
Cys Val Leu Ser
C17H32N4O6S (420.20424520000006)
Cys Val Ser Ile
C17H32N4O6S (420.20424520000006)
Cys Val Ser Leu
C17H32N4O6S (420.20424520000006)
Cys Val Thr Val
C17H32N4O6S (420.20424520000006)
Cys Val Val Thr
C17H32N4O6S (420.20424520000006)
Phe Ala Ala Ile
Phe Ala Ala Leu
Phe Ala Ile Ala
Phe Ala Leu Ala
Phe Gly Val Val
Phe Ile Ala Ala
Phe Leu Ala Ala
Phe Val Gly Val
Phe Val Val Gly
Gly Phe Val Val
Gly Ile Met Thr
C17H32N4O6S (420.20424520000006)
Gly Ile Thr Met
C17H32N4O6S (420.20424520000006)
Gly Leu Met Thr
C17H32N4O6S (420.20424520000006)
Gly Leu Thr Met
C17H32N4O6S (420.20424520000006)
Gly Met Ile Thr
C17H32N4O6S (420.20424520000006)
Gly Met Leu Thr
C17H32N4O6S (420.20424520000006)
Gly Met Thr Ile
C17H32N4O6S (420.20424520000006)
Gly Met Thr Leu
C17H32N4O6S (420.20424520000006)
Gly Thr Ile Met
C17H32N4O6S (420.20424520000006)
Gly Thr Leu Met
C17H32N4O6S (420.20424520000006)
Gly Thr Met Ile
C17H32N4O6S (420.20424520000006)
Gly Thr Met Leu
C17H32N4O6S (420.20424520000006)
Gly Val Phe Val
Gly Val Val Phe
His Ala Pro Pro
His Pro Ala Pro
His Pro Pro Ala
Ile Ala Ala Phe
Ile Ala Phe Ala
Ile Ala Met Ser
C17H32N4O6S (420.20424520000006)
Ile Ala Ser Met
C17H32N4O6S (420.20424520000006)
Ile Cys Ser Val
C17H32N4O6S (420.20424520000006)
Ile Cys Val Ser
C17H32N4O6S (420.20424520000006)
Ile Phe Ala Ala
Ile Gly Met Thr
C17H32N4O6S (420.20424520000006)
Ile Gly Thr Met
C17H32N4O6S (420.20424520000006)
Ile Met Ala Ser
C17H32N4O6S (420.20424520000006)
Ile Met Gly Thr
C17H32N4O6S (420.20424520000006)
Ile Met Ser Ala
C17H32N4O6S (420.20424520000006)
Ile Met Thr Gly
C17H32N4O6S (420.20424520000006)
Ile Ser Ala Met
C17H32N4O6S (420.20424520000006)
Ile Ser Cys Val
C17H32N4O6S (420.20424520000006)
Ile Ser Met Ala
C17H32N4O6S (420.20424520000006)
Ile Ser Thr Thr
Ile Ser Val Cys
C17H32N4O6S (420.20424520000006)
Ile Thr Gly Met
C17H32N4O6S (420.20424520000006)
Ile Thr Met Gly
C17H32N4O6S (420.20424520000006)
Ile Thr Ser Thr
Ile Thr Thr Ser
Ile Val Cys Ser
C17H32N4O6S (420.20424520000006)
Ile Val Ser Cys
C17H32N4O6S (420.20424520000006)
Leu Ala Ala Phe
Leu Ala Phe Ala
Leu Ala Met Ser
C17H32N4O6S (420.20424520000006)
Leu Ala Ser Met
C17H32N4O6S (420.20424520000006)
Leu Cys Ser Val
C17H32N4O6S (420.20424520000006)
Leu Cys Val Ser
C17H32N4O6S (420.20424520000006)
Leu Phe Ala Ala
Leu Gly Met Thr
C17H32N4O6S (420.20424520000006)
Leu Gly Thr Met
C17H32N4O6S (420.20424520000006)
Leu Met Ala Ser
C17H32N4O6S (420.20424520000006)
Leu Met Gly Thr
C17H32N4O6S (420.20424520000006)
Leu Met Ser Ala
C17H32N4O6S (420.20424520000006)
Leu Met Thr Gly
C17H32N4O6S (420.20424520000006)
Leu Ser Ala Met
C17H32N4O6S (420.20424520000006)
Leu Ser Cys Val
C17H32N4O6S (420.20424520000006)
Leu Ser Met Ala
C17H32N4O6S (420.20424520000006)
Leu Ser Thr Thr
Leu Ser Val Cys
C17H32N4O6S (420.20424520000006)
Leu Thr Gly Met
C17H32N4O6S (420.20424520000006)
Leu Thr Met Gly
C17H32N4O6S (420.20424520000006)
Leu Thr Ser Thr
Leu Thr Thr Ser
Leu Val Cys Ser
C17H32N4O6S (420.20424520000006)
Leu Val Ser Cys
C17H32N4O6S (420.20424520000006)
Met Ala Ile Ser
C17H32N4O6S (420.20424520000006)
Met Ala Leu Ser
C17H32N4O6S (420.20424520000006)
Met Ala Ser Ile
C17H32N4O6S (420.20424520000006)
Met Ala Ser Leu
C17H32N4O6S (420.20424520000006)
Met Ala Thr Val
C17H32N4O6S (420.20424520000006)
Pro Ala His Pro
Pro Ala Pro His
Pro His Ala Pro
Pro His Pro Ala
Pro Pro Ala His
Pro Pro His Ala
Ser Ile Thr Thr
Ser Leu Thr Thr
Ser Thr Ile Thr
Ser Thr Leu Thr
Ser Thr Thr Ile
Ser Thr Thr Leu
Thr Ile Ser Thr
Thr Ile Thr Ser
Thr Leu Ser Thr
Thr Leu Thr Ser
Thr Ser Ile Thr
Thr Ser Leu Thr
Thr Ser Thr Ile
Thr Ser Thr Leu
Thr Thr Ile Ser
Thr Thr Leu Ser
Thr Thr Ser Ile
Thr Thr Ser Leu
Thr Thr Thr Val
Thr Thr Val Thr
Thr Val Thr Thr
Val Phe Gly Val
Val Phe Val Gly
Val Gly Phe Val
Val Gly Val Phe
Val Thr Thr Thr
Val Val Phe Gly
Val Val Gly Phe
Cabastine
C26H29FN2O2 (420.22129459999996)
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Dimethyl 3-methoxy-4-oxo-5-(8,11,14-pentadecatrienyl)-2-hexenedioate
1-oleyl glycerone-3-phosphate
C21H41O6P (420.26406160000005)
1-vaccenyl glycerone-3-phosphate
C21H41O6P (420.26406160000005)
17-Oxo-6,9,12-trioxa-2,16-diazaeicosanedioic acid 1-(1,1-dimethylethyl)ester
tert-Butyl 4-(2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine-1-carboxylat95
Brifentanil
C20H29FN6O3 (420.22850559999995)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
sodium 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl sulphate
C18H37NaO7S (420.21575720000004)
Pipebuzone
C25H32N4O2 (420.25251319999995)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt
1-BOC-4-(2-CBZ-AMINO-2-METHOXYCARBONYL-ETHYL)PIPERIDINE
Ralimetinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
13-cis-12-(3-Carboxyphenyl)retinoic acid
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(8alpha,10alpha,13alpha,17beta)-17-[(4-Hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
Methyl 6-(acetyloxy)-1,7,11-trihydroxyabieta-8(14),9(11),12-trien-18-oate
Vascor
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents
12-Acetyloxy-10-(acetyloxymethyl)-6-methyl-2-(4-methylpent-3-enyl)dodeca-2,6,10-trienoic acid
tert-butyl 4-[5-(4-phenoxyphenyl)-1H-pyrazol-3-yl]piperazine-1-carboxylate
1-Oleylglycerone 3-phosphate
C21H41O6P (420.26406160000005)
A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as oleyl
(3E,5E,7E,10R,12R,13E,17R,18S,22S)-22-ethyl-10,12,18-trihydroxy-17-methyl-1-oxacyclodocosa-3,5,7,13-tetraene-2,16-dione
[(5R,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E)-6,7-dihydroxyocta-2,4-dienoate
(2R)-2-hydroxy-3-{[(1Z)-octadec-1-en-1-yl]oxy}propyl phosphate
C21H41O6P-2 (420.26406160000005)
Cadiyenol
An acetylenic compound that is (8E)-heptadeca-1,8-diene-4,6-diyne substituted by hydroxy group at positions 6 and 15, a methoxy group at position 8 and a (5-methoxy-5-oxopentyl)oxy group at position 7. Isolated from Centella asiatica, it exhibits antineoplastic activity.
1-Oleyl-sn-glycero-3-phosphate(2-)
C21H41O6P-2 (420.26406160000005)
1-Octadecylglycerone 3-phosphate(2-)
C21H41O6P-2 (420.26406160000005)
1-[1-[1-(1,3-Benzodioxol-5-ylmethyl)-5-tetrazolyl]-2-methylpropyl]-4-phenylpiperazine
N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline hydrochloride--water (1/1)
1-[3-(dimethylamino)propyl]-1-[(5,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-3-(phenylmethyl)urea
C25H32N4O2 (420.25251319999995)
6-[(2E,6E)-4,5-Dihydroxy-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
2-[(2S,3R,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,3S,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
[(1R,2aR,8bR)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclohexylmethanone
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
C25H28N2O4 (420.20489680000003)
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
C25H28N2O4 (420.20489680000003)
1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(3-pyridinyl)ethanone
1-[(2S,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
C25H28N2O4 (420.20489680000003)
1-[(2R,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
C25H28N2O4 (420.20489680000003)
N-(2-hydroxyphenyl)-N-[(E)-(1-methylindol-3-yl)methylideneamino]octanediamide
2-[(2S,3R,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3S,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3S,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3R,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,3S,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3R,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[2-(4-morpholinyl)-1-oxoethyl]amino]ethyl]-3-oxanyl]-2-(2-pyridinyl)acetamide
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5R,8S)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5R,8R)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
[(1S,2aR,8bR)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclohexylmethanone
[(1R,2aS,8bS)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclohexylmethanone
[(1S,2aS,8bS)-1-(hydroxymethyl)-2-[(2-methoxyphenyl)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-cyclohexylmethanone
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
C25H28N2O4 (420.20489680000003)
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
C25H28N2O4 (420.20489680000003)
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
1-[(2R,3S)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
C25H28N2O4 (420.20489680000003)
1,7-Bis(3,5-diethyl-4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
(6aS,6bS,8aS,11R,14aR)-3-hydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
(2-hydroxy-3-phosphonooxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate
(8xi,9xi,14xi,17xi)-3,5,14,19-Tetrahydroxy-19-oxocard-20(22)-enolide
[(4E,8E)-2-acetamido-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
(6aR,6bR,8aS,11R,12aR,14aR)-3-hydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
D000970 - Antineoplastic Agents
1-Octadecanoyl-cyclophosphatidic acid
C21H41O6P (420.26406160000005)
1-stearoyl-cyclic phosphatidic acid
C21H41O6P (420.26406160000005)
1-Oleyl-sn-glycero-3-phosphate(2-)
C21H41O6P (420.26406160000005)
A 1-alkyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleyl-sn-glycero-3-phosphate; major species at pH 7.3.
1-Octadecylglycerone 3-phosphate(2-)
C21H41O6P (420.26406160000005)
A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-octadecylglycerone 3-phosphate; major species at pH 7.3.
1-(1Z-octadecenyl)-sn-glycero-3-phosphate(2-)
C21H41O6P (420.26406160000005)
A 1-(Z)-alk-1-enyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of any 1-(1Z-octadecenyl)-sn-glycero-3-phosphate; major species at pH 7.3.
2-hydroxy-1,3-dimethoxy-6-methyl-5-(prop-2-en-1-yl)-7-(3,4,5-trimethoxyphenyl)bicyclo[3.2.1]octan-8-one
(1r,2s,3r,6r,7r,8r,9r,13z)-9-(acetyloxy)-6-isopropyl-3,9,13-trimethyl-12-oxo-15-oxatricyclo[6.6.1.0²,⁷]pentadec-13-en-3-yl acetate
(3r,4as,6r,6as,8s,10as,10br)-8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-6-yl acetate
methyl (1s,2s,3s,6r,7s,10r,11r,12r)-2-[5-(2h-1,3-benzodioxol-5-yl)pentyl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate
(1r,2r,3as,3br,5as,7r,8r,9ar,9bs,11ar)-2,3a,7,8-tetrahydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde
methyl (1s,2s,3r,6r,7r,10s,11s,12s)-2-[5-(2h-1,3-benzodioxol-5-yl)pentyl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylate
11'-(acetyloxy)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl 5-hydroxy-3-methylpent-2-enoate
2,4,8-trimethyl (1r,2s,3r,4r,6r,8r,9r,12r)-6-hydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadecane-2,4,8-tricarboxylate
(6bs,8ar,11s,12as,12br,14as)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
5-[6,7-bis(acetyloxy)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid
(1s,2r,4as,5'r,5''r,8as)-5''-methoxy-2,5,5,8a-tetramethyl-4-methylidene-3-oxo-tetrahydrodispiro[naphthalene-1,2':5',3''-bis(oxolane)]-2-yl acetate
4,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-2h,3h,4h,6h,7h,8h,10ah,13h,13ah,14h-1-oxa-2-azacyclododeca[12,11-d]isoindol-5-one
5-methoxy-2-methyl-4-[(1r,6r)-4-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol
2a,4-dihydroxy-3-(hydroxymethyl)-6,6,7b-trimethyl-octahydrocyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
(2s)-2-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-3-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]propanoic acid
C25H28N2O4 (420.20489680000003)
(5-hydroxy-3-methylidene-6-{[(2-methylpropanoyl)oxy]methyl}-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-10-yl)methyl 2-methylpropanoate
13-(acetyloxy)-11-hydroxy-4,9,12-trimethyl-15-(prop-1-en-2-yl)-5-oxatricyclo[10.3.0.0⁴,⁶]pentadec-9-en-2-yl acetate
(2r)-2-[(1r,3ar,8as)-1,4,4-trimethyl-8-methylidene-hexahydro-2h-azulen-1-yl]-2-[(3r,4s)-4-(acetyloxy)-5-oxooxolan-3-yl]ethyl acetate
(1r,2s,3r,6r,7r,8r,9r)-9-(acetyloxy)-6-isopropyl-3,9-dimethyl-13-methylidene-12-oxo-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-3-yl acetate
(5e,7e,9e,11e,13e,15e,17e,19z,21e,23e)-3-hydroxy-24-methyl-25-oxohexacosa-5,7,9,11,13,15,17,19,21,23-decaenoic acid
(4s,6r,10as,13s,13as,14s,16ar)-4,6,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-2h,3h,4h,6h,7h,8h,10ah,13h,13ah,14h-1-oxa-2-azacyclododeca[11,12-d]isoindol-5-one
(2r)-2,3-dihydroxypropyl (2e,4e)-5-[(1r,7s,8r,9r)-7-hydroxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate
[(1r,2s,4s,5s,6r,9r,10s,13r,16s)-16-(acetyloxy)-2,6-dihydroxy-5,9,13-trimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl acetate
2-[(8z,10r)-10-(acetyloxy)pentadec-8-en-1-yl]-4,6-dihydroxybenzoic acid
(1r,3as,3br,5as,7s,9as,9bs,11r,11as)-3a,5a,7,11-tetrahydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
3,4a,6',7,7',11a-hexamethyl-5,6,6a,11b-tetrahydro-1h,3'h-spiro[cyclohepta[a]naphthalene-4,2'-furo[3,2-c]pyran]-4',9-dione
5-[(2s,3s)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-3-methoxybenzene-1,2-diol
[6-(acetyloxy)-12,15-dihydroxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl acetate
4a-hydroxy-4,4,11b-trimethyl-7-methylidene-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl benzoate
8-(acetyloxy)-3-ethenyl-3,4a,7,7,10a-pentamethyl-5-oxo-octahydronaphtho[2,1-b]pyran-6-yl acetate
(6bs,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione
18-hydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl butanoate
n-{1-[6-(ethylsulfanyl)-3,4,5-trihydroxyoxan-2-yl]-2-hydroxypropyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C19H36N2O6S (420.22939560000003)